Journal of Psychiatry Reform
  • About us
  • How to Contribute
  • FAQ
  • Contact us
ISSN 2371-4301
Search
  • Home
  • Editorials & Commentary
  • Papers
    • Review Articles
  • Abstracts
  • Educational Programs
  • Members
  • Contact us
BIG PHARMA’S COVERT STRATEGIES AND THE SUBVERSION OF PSYCHIATRIC DIAGNOSIS.
  • November 24, 2015,
  • 0Comments

EDITORIAL Many physicians assume they are immune to the advertising and marketing strategies of  pharmaceutical companies. Physicians are confident in their own knowledge and judgment and believe that they will not be overly influenced by a p..

  • Posted by Alan Eppel
  • Posted in Editorials & Commentary
BIPOLAR DISORDER: WHY LITHIUM IS STILL FIRST CHOICE
  • December 2, 2015,
  • 0Comments

Journal Abstracts Nervenarzt. 2014 Sep;85(9):1166-70. doi: 10.1007/s00115-014-4083-x. [New facts of long-term prophylaxis for bipolar affective disorder]. [Article in German] Bschor T1, Müller-Oerlinghausen B, Stoppe G, Hiemke C.   ..

  • Posted by Alan Eppel
  • Posted in Review Articles
ARIPIPRAZOLE in DEPRESSION and ANXIETY: BUYER BEWARE!
  • January 9, 2016,
  • 0Comments

                              ALAN EPPEL MB, FRCPC Attached to the cover of a recent issue of the ..

  • Posted by Alan Eppel
  • Posted in Review Articles
Clozapine recent abstracts
  • December 29, 2016,
  • 0Comments

In the December 2016 issue of JPR we feature recent abstracts relating to Clozapine. The first abstract is from a group in Brisbane Australia who found that Clozapine is superior for the treatment of positive symptoms in refractory schizophren..

  • Posted by Editor JPR
  • Posted in Abstracts
Creative Commons License
This work is licensed under a Creative Commons Attribution Non-Commercial No-Derivatives 4.0 International License.